Form 4 for SANA Sana Biotechnology, Inc.
Accepted 2023-02-17 00:00:00 ET · period of report 2021-02-03 · accession 0001562180-23-001518 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-02-17 | 2021-02-03 | SANA | Bilenker Joshua H. | Dir | P - Purchase | $25.00 | +20.0K | 20.0K | New | +$500.0K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2021-02-03 | P | A | 20,000 | $25.00 | 20,000 | D | — | — |